Keyword: Yitzhak Peterburg
Thousands of job cuts are slated to hit Teva's home country of Israel on Thursday, reports say.
Back in January, when troubled Teva walked back its guidance by $1 billion-plus, some analysts worried it might still be too high. They were right.
Israel’s Teva is suing a former U.S. employee over allegations she shared company secrets with her boyfriend, the CEO of rival Apotex.
Teva confirms that it's not only looking for an outsider to lead the company. It wants a seasoned pharma CEO.
Yet another key Teva exec could be bowing out in the company’s time of need—and that’s CFO Eyal Desheh.
Teva execs may have zeroed in on their first big revamp move since CEO Erez Vigodman's sudden exit.